-
FDA Drug Safety Panel Member Composition Is Criticized by Senator Grassley and FDA’s Graham
Concern About Panel’s Independence May Create Support for Pending Grassley-Dodd Bill Due in large part to the types of people who have been appointed as members , Senator Charles E. Grassley (R-Iowa) and FDA…
-
3,017 Baycol / Lipobay Cases Settled by Bayer as of June 30, 2005
Bayer Has Paid Out $1.138 Billion; Average Baycol Settlement is $377,195 On August 10, 2005 it was reported that as of June 30, 2005 Bayer AG has paid $1.138 billion to settle 3,017 injury…
-
Natrecor: Medical Experts Adamant About Their Advice Given to Scios / Johnson & Johnson
Natrecor Advisory Panel Report is Probably Not What Drug Maker Expected, or Wanted In the August 9, 2005 edition of The New York Times, reporter Stephanie Saul succinctly characterized the current Natrecor situation: "Call…
-
MedEffect: The New Drug-safety Web Site from Health Canada
Intended to Collect Adverse Drug Reaction Information from, and for, Canadians On August 9, 2005 Health Canada launched "MedEffect", which is a new web site dedicated to collecting adverse drug reaction reports from Canadian…
-
Johnson & Johnson Attempts to Restrict Prescribing Of Heart-failure Drug Natrecor
Drug Company Warns Doctors Against "Off Label" Use of Natrecor at Clinics Johnson & Johnson is apparently acting on some two-month old advice from an expert panel of cardiologists in attempting to restrict the…
-
NEJM Publishes and Then, in the Same Edition, Challenges a Company-sponsored Study Article
A Classic Example of Medical Journal Manipulation by Pharmaceutical Industry? In the August 4, 2005 edition of the New England Journal Of Medicine, an editorial piece seems to cast some doubt on a research…
